While not a miracle cure, these treatments support the body’s natural processes in ways that may aid those struggling with stubborn weight gain, fatigue, and metabolic slowdown.
1
In 2024, the global oligonucleotide synthesis market was valued at USD 4.05 billion. It is forecasted to reach USD 8.83 billion by 2030, reflecting a robust compound annual growth rate (CAGR) of 13.2% from 2025 through 2030.
The global Ultomiris drug market size is poised for significant expansion, with its market size projected to grow from USD 5.2 billion in 2025 to USD 14.9 billion by 2033, reflecting a strong compound annual growth rate (CAGR) of 14.4% during the forecast period.
The global tax management software market was valued at USD 18.74 billion in 2022 and is expected to reach USD 39.71 billion by 2030.